Evidence map›Paper›PMID 42871692›Full record

ArticleJournal of biomedical physics & engineering2026

An [18F]-FDG PET/CT Image Dataset for Artificial Intelligence-Based Classification of Lung Cancer.

Mohammad Karimpour, Alireza Mehdizadeh, Mehrosadat Alavi, Tahereh Mahmoudi

Abstract read
In one paragraph

Article in Journal of biomedical physics & engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mohammad KarimpourDepartment of Medical Physics and Engineering, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Alireza MehdizadehResearch Center for Neuromodulation and Pain, Shiraz University of Medical Sciences, Shiraz, Iran.
Mehrosadat AlaviDepartment of Nuclear Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Tahereh MahmoudiDepartment of Medical Physics and Engineering, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lung cancer is a leading cause of cancer-related mortality worldwide. [18F]-fluorodeoxyglucose ([18F]-FDG) Positron Emission Tomography/Computed Tomography (PET/CT) imaging is an advanced medical imaging modality used for lung cancer diagnosis. However, despite the availability of such an imaging modality, current methods of diagnosing cancer and interpreting images are prone to error. Therefore, Artificial Intelligence (AI)-based methods for medical image analysis are introduced and widely applied to enhance diagnostic accuracy. These methods, particularly deep learning techniques, require large datasets. Collecting image datasets, especially PET/CT images, is time-consuming, labor-intensive, and in some instances impossible due to the high costs and low availability of imaging centers. To facilitate further research in AI for lung cancer diagnosis, we present a publicly available 2D [18F]-FDG PET/CT lung image dataset comprising 3,061 image slices obtained from 94 patients. The dataset provides pathology-confirmed ground truth annotations together with patient-level identifiers, making it suitable for developing, validating, benchmarking, and comparing AI algorithms for lung cancer classification, localization, explainable AI, and other PET/CT-based computer-aided diagnostic applications.

Indexed as

Artificial IntelligenceComputer-Aided DiagnosisLung CancerMedical Image DatasetNon-Small Cell Lung CarcinomaPositron Emission Tomography Computed TomographySmall Cell Lung Carcinoma

Identifiers

PMID42871692
PMCPMC13658906

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.